Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Maosheng Fang"'
Autor:
Qian Li, Yun-Ai Su, Xuemei Liao, Maosheng Fang, Jianliang Gao, Jia Xu, Mingjun Duan, Haiying Yu, Yang Yang, Zhiyu Chen, Jintong Liu, Shaoxiao Yan, Peifen Yao, Shuying Li, Changhong Wang, Bin Wu, Congpei Zhang, Tianmei Si
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
ObjectivesTo investigate the effect of aripiprazole on prolactin levels in patients with schizophrenia and analyze whether varying baseline prolactin levels affect the effectiveness and safety of aripiprazole, in a real-life diagnostic and therapeuti
Externí odkaz:
https://doaj.org/article/f322b2d6ba294bc5af88f863d6e7bca2
Autor:
Yujun Long, Qiongqiong Wu, Ye Yang, Jingda Cai, Jingmei Xiao, Zhaoqian Liu, Yifeng Xu, Ying Chen, Manli Huang, Ruiguo Zhang, Xijia Xu, Jian Hu, Zhifen Liu, Fang Liu, Yingjun Zheng, Huaqing Meng, Zhimin Wang, Yanqing Tang, Xueqin Song, Yunchun Chen, Xueyi Wang, Tiebang Liu, Xiaoli Wu, Maosheng Fang, Chunling Wan, Jingping Zhao, Renrong Wu
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background It remains a challenge to predict the long-term response to antipsychotics in patients with schizophrenia who do not respond at an early stage. This study aimed to investigate the optimal predictive cut-off value for early non-res
Externí odkaz:
https://doaj.org/article/e9f650828e394612806d25890b2328c1
Autor:
Shen He, Yimin Yu, Jingjing Huang, Jiahui Yin, Yajuan Niu, Yazhou Lu, Bin Wu, Maosheng Fang, Xue Wang, Zhiping Tao, Lehua Li, Kan Li, Yan Li, Xiujuan Ding, Yifeng Shen, Huafang Li
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 13 (2023)
Background: Almost one-third of patients with major depressive disorder (MDD) do not respond to conventional antidepressants, and new treatments for MDD are urgently needed. Objectives: This phase IIb clinical trial was designed to evaluate the effic
Externí odkaz:
https://doaj.org/article/cb6e6a95267e423db2992f27683b93e2
Autor:
Qian Li, Yun’ai Su, Xuemei Liao, Maosheng Fang, Jianliang Gao, Jia Xu, Mingjun Duan, Haiying Yu, Yang Yang, Zhiyu Chen, Jintong Liu, Shaoxiao Yan, Peifen Yao, Shuying Li, Changhong Wang, Bin Wu, Congpei Zhang, Tianmei Si, Peifang Wei, Xiangxiang Pan
Publikováno v:
Chinese Medical Journal, Vol 136, Iss 9, Pp 1126-1128 (2023)
Externí odkaz:
https://doaj.org/article/880954475c53474e99487fb95e73db66
Autor:
Xiaohui Wu, Yuncheng Zhu, Zhiguo Wu, Jia Huang, Lan Cao, Yun Wang, Yousong Su, Hongmei Liu, Maosheng Fang, Zhijian Yao, Zuowei Wang, Fan Wang, Yong Wang, Daihui Peng, Jun Chen, Yiru Fang
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
BackgroundTwo-thirds of major depressive disorder (MDD) patients initially present with somatic symptoms, yet no study has used approaches based on somatic symptoms to subtype MDD. This study aimed to classify MDD via somatic symptoms and tracked the
Externí odkaz:
https://doaj.org/article/b74fd3c0d5484df493ceb2e4cb17a4cd
Autor:
Zuowei Wang, Jia Huang, Yousong Su, Daihui Peng, Lan Cao, Yiru Fang, Jun Chen, Yun Wang, Maosheng Fang, Zhijian Yao, Zhiguo Wu, Fan Wang, Yuncheng Zhu, Yong Wang, Lu Yang
Publikováno v:
Journal of Psychiatric Research. 138:96-102
Effective and targeted interventions for improving quality of life (QOL) in addition to achieving 'clinical remission' are imperatives for patients with major depressive disorder (MDD). This study aimed to examine potential predictors and moderators
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b44b28500bbbc4bbbb681fbfcff44ebf
https://doi.org/10.1016/j.jpsychires.2021.03.063
https://doi.org/10.1016/j.jpsychires.2021.03.063
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0167930 (2016)
Atypical antipsychotics such as olanzapine cause metabolic side effects leading to obesity and insulin resistance. The underlying mechanisms remain elusive. In this study we investigated the effects of chronic treatment of olanzapine on the fatty aci
Externí odkaz:
https://doaj.org/article/b41b440c31a44804bec5138d425ce066
Autor:
Xiaohui Wu, Yuncheng Zhu, Zhiguo Wu, Jia Huang, Lan Cao, Yun Wang, Yousong Su, Hongmei Liu, Maosheng Fang, Zhijian Yao, Zuowei Wang, Fan Wang, Yong Wang, Daihui Peng, Jun Chen, Yiru Fang
Publikováno v:
Frontiers in psychiatry. 13
BackgroundTwo-thirds of major depressive disorder (MDD) patients initially present with somatic symptoms, yet no study has used approaches based on somatic symptoms to subtype MDD. This study aimed to classify MDD via somatic symptoms and tracked the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb9fa302b99320e57e8ae1b6a529d101
https://pubmed.ncbi.nlm.nih.gov/35903631
https://pubmed.ncbi.nlm.nih.gov/35903631
Autor:
Pinglan Liu, Gang Wang, Fuxi Wu, Maosheng Fang, Hongjun Tian, Lingyue Ma, Changqing Hu, Song Chen, Youxin Li, Meng Fang, Xia Zhao, Zining Wang, Kaoxiang Sun, Qian Xiang, Yimin Cui, Yunlong Tan, Nan Zhao
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 109:110241
Background LY03004, a novel investigational risperidone long-acting injection (LAI) microsphere formulation, can release risperidone more quickly after injection than Risperdal Consta®. This study aimed to investigate the effects of genetic polymorp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bc11363193dfc12ede0ae36ac084606
https://doi.org/10.1016/j.pnpbp.2020.110241
https://doi.org/10.1016/j.pnpbp.2020.110241
Autor:
F. Yang, Gang Wang, Jianmin Zhuo, Xinhua Shen, Jicheng Dong, Jijun Li, Tian-Mei Si, Jinan Wang, Hu Cuili, Maosheng Fang, Yiru Fang, Qing Rui
Publikováno v:
Metabolic Brain Disease. 32:891-901
Severe depression accounts for one-third of depressed patients. Increasing severity of depression usually hinders patients from achieving remission. This study evaluated the efficacy and safety of escitalopram in acute-phase treatment of severe major
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ca10b9614fe9e72be0886c0a83ed041
https://doi.org/10.1007/s11011-017-9992-5
https://doi.org/10.1007/s11011-017-9992-5